<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19515" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Chromosome Instability Syndromes</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rayi</surname>
            <given-names>Appaji</given-names>
          </name>
          <aff>Charleston Area Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hozayen</surname>
            <given-names>Sameh</given-names>
          </name>
          <aff>Sovah Health</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Appaji Rayi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sameh Hozayen declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>19</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19515.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Chromosomal instability syndromes are a group of rare, inherited disorders characterized by a predisposition to chromosomal instability and breakage, either spontaneously or in response to deoxyribonucleic acid (DNA)-damaging agents. These syndromes are caused by defects in proteins or enzymes essential for DNA repair and chromosomal maintenance, leading to a higher risk of immunodeficiency, infections, and the development of certain cancers. Well-known examples include ataxia-telangiectasia, Bloom syndrome, Fanconi anemia, and Nijmegen breakage syndrome. Diagnosis often requires genetic testing and the evaluation of chromosomal breakage. Given the complexity of these disorders, patients require a comprehensive management approach that includes genetic counseling, tailored cancer surveillance, and infectious disease consultation.</p>
        <p>This course educates participants on the clinical evaluation, diagnosis, and management of chromosomal instability syndromes, including how to recognize their genetic and clinical features. This course highlights the importance of early detection and intervention to mitigate complications such as immunodeficiency and cancer. Collaboration among an interprofessional team&#x02014;including geneticists, oncologists, infectious disease specialists, and primary care clinicians&#x02014;is crucial for creating personalized care plans. By working together, the team can enhance patient outcomes through coordinated care, ongoing surveillance, and effective treatment strategies that address the multifaceted needs of these patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the clinical signs and symptoms associated with major chromosomal instability syndromes such as ataxia-telangiectasia, Bloom syndrome, and Fanconi anemia.</p></list-item><list-item><p>Differentiate between various chromosomal instability syndromes based on genetic and clinical findings, including immunodeficiency and cancer risk.</p></list-item><list-item><p>Screen patients with recurrent infections or unexplained malignancies for potential chromosomal instability through appropriate genetic testing.</p></list-item><list-item><p>Communicate&#x000a0;the role of the health professional team in coordinating the care of a patient with chromosomal instability syndromes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19515&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19515">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-19515.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Chromosomal instability syndromes are a group of inherited disorders associated with chromosomal instability and breakage spontaneously or in response to deoxyribonucleic acid (DNA)-damaging agents.<xref ref-type="bibr" rid="article-19515.r1">[1]</xref>&#x000a0;Most of these syndromes are significant because they are associated with variable degrees of immunodeficiency, infectious disease, and the risk of developing certain malignancies.<xref ref-type="bibr" rid="article-19515.r2">[2]</xref>&#x000a0;The following chromosomal instability syndromes are rare but well-described:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ataxia-telangiectasia&#x000a0;<xref ref-type="bibr" rid="article-19515.r3">[3]</xref></p>
          </list-item>
          <list-item>
            <p>Bloom syndrome&#x000a0;<xref ref-type="bibr" rid="article-19515.r4">[4]</xref></p>
          </list-item>
          <list-item>
            <p>Fanconi anemia&#x000a0;<xref ref-type="bibr" rid="article-19515.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Nijmegen breakage syndrome&#x000a0;<xref ref-type="bibr" rid="article-19515.r6">[6]</xref></p>
          </list-item>
        </list>
        <p>Other rare syndromes include ataxia telangiectasia-like disorder; immunodeficiency, centromeric instability, and facial anomalies syndromes;<bold>&#x000a0;</bold>Cockayne syndrome; trichothiodystrophy; xeroderma pigmentosum; DNA ligase I deficiency; <italic toggle="yes">PMS2</italic> deficiency; and DNA recombinase repair defects (DNA-phosphatidylinositol 3-kinase, Artemis, DNA ligase 4, Cernunnos).<xref ref-type="bibr" rid="article-19515.r7">[7]</xref><xref ref-type="bibr" rid="article-19515.r8">[8]</xref><xref ref-type="bibr" rid="article-19515.r9">[9]</xref><xref ref-type="bibr" rid="article-19515.r10">[10]</xref><xref ref-type="bibr" rid="article-19515.r11">[11]</xref><xref ref-type="bibr" rid="article-19515.r12">[12]</xref><xref ref-type="bibr" rid="article-19515.r13">[13]</xref></p>
      </sec>
      <sec id="article-19515.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Chromosomal instability syndromes show chromosomal instability because defective proteins or enzymes spontaneously lead to chromosomal breakage or in response to DNA-damaging agents.&#x000a0;<xref ref-type="bibr" rid="article-19515.r2">[2]</xref></p>
      </sec>
      <sec id="article-19515.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Incidence rates for the following rare chromosomal instability syndromes are:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Ataxia-telangiectasia:</bold>&#x000a0;One in 40,000 to 100,000 live births have this condition.<xref ref-type="bibr" rid="article-19515.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Bloom syndrome:</bold>&#x000a0;This condition has been reported across different ethnicities but is common in Eastern European (Ashkenazi) Jews; estimated carrier frequency of 1 in 120.<xref ref-type="bibr" rid="article-19515.r15">[15]</xref><xref ref-type="bibr" rid="article-19515.r16">[16]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Fanconi anemia:</bold>&#x000a0;Although a rare syndrome,&#x000a0;it's&#x000a0;a common inherited bone marrow failure syndrome; cases are reported across all racial and ethnic groups.<xref ref-type="bibr" rid="article-19515.r17">[17]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Nijmegen breakage syndrome:</bold>&#x000a0;This is more common in individuals with Eastern European ancestry.<xref ref-type="bibr" rid="article-19515.r18">[18]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19515.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Although the pathophysiology of these disorders is secondary to different deficits, the final common pathway to chromosomal instability is due to an increased risk of DNA damage or defective DNA repair mechanisms.</p>
        <p>
<bold>Ataxia-Telangiectasia</bold>
</p>
        <p>Ataxia-telangiectasia is an autosomal recessive disorder that primarily presents with cerebellar ataxia; this results from a mutation in the&#x000a0;ataxia telangiectasia mutated&#x000a0;(<italic toggle="yes">ATM</italic>)&#x000a0;gene, which leads to a total loss of ATM protein (classic type)&#x000a0;or a reduction of its level (wild-type).<xref ref-type="bibr" rid="article-19515.r3">[3]</xref><bold>&#x000a0;</bold>In normal conditions, the&#x000a0;ATM protein recognizes DNA damage and activates DNA repair mechanisms to reduce genetic damage. The defect in the regulatory functions of the <italic toggle="yes">ATM</italic> gene causes somatic mutations that lead to the manifestations of the disease.</p>
        <p>
<bold>Bloom Syndrome</bold>
</p>
        <p>Bloom syndrome is an autosomal recessive disease caused by a lack of BLM helicase enzyme, resulting from a mutation in the <italic toggle="yes">BLM</italic> gene.&#x000a0;<italic toggle="yes">BLM</italic> gene encodes a RecQ helicase and RECQL3, referred to as the Bloom syndrome protein (BLM), which helps maintain DNA stability, especially during recombination repair and replication. The protein is also involved with other molecules involved in DNA damage surveillance and repair.<xref ref-type="bibr" rid="article-19515.r19">[19]</xref><xref ref-type="bibr" rid="article-19515.r20">[20]</xref></p>
        <p>
<bold>Fanconi Anemia</bold>
</p>
        <p>Fanconi anemia&#x000a0;is a DNA repair disorder where cells cannot repair DNA damage caused by interstrand cross-links. This defect eventually leads to chromosomal instability, particularly upon exposure to cytotoxic therapies, and a general predisposition to certain cancers. Fanconi anemia can result from a mutation in any of the 17 different Fanconi anemia genes (<italic toggle="yes">FANCA</italic> to <italic toggle="yes">FANCQ</italic>). The most commonly mutated genes in patients with Fanconi anemia are <italic toggle="yes">FANCA</italic>, <italic toggle="yes">FANCC</italic>, and <italic toggle="yes">FANCG</italic>. Inheritance patterns include autosomal recessive, autosomal dominant, and X-linked.<xref ref-type="bibr" rid="article-19515.r17">[17]</xref></p>
        <p>
<bold>Nijmegen Breakage Syndrome</bold>
</p>
        <p>Nijmegen breakage syndrome is an autosomal recessive chromosome instability syndrome associated with immunodeficiency. Nijmegen breakage syndrome results from mutations in the nibrin (<italic toggle="yes">NBN</italic>) gene on 8q21. The protein product is involved in DNA double-strand breaks repair, base excision repair, meiotic recombination, and telomere maintenance.<xref ref-type="bibr" rid="article-19515.r21">[21]</xref><xref ref-type="bibr" rid="article-19515.r22">[22]</xref></p>
      </sec>
      <sec id="article-19515.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>Ataxia-Telangiectasia</bold>
</p>
        <p>In classic form,&#x000a0;ataxia-telangiectasia patients present early with ataxia (gait impairment, hand incoordination, and eye movement dysfunction), and conjunctival&#x000a0;telangiectasias occur during school age.<xref ref-type="bibr" rid="article-19515.r23">[23]</xref><bold>&#x000a0;</bold>Recurrent sinopulmonary infections are secondary to the reduction of immunoglobulins and the reduction of&#x000a0;newly produced B and T cells.<xref ref-type="bibr" rid="article-19515.r24">[24]</xref>&#x000a0;These infections can further progress into bronchiectasis and pulmonary fibrosis. Young adults have an increased risk of hematological malignancies, including lymphoma and leukemia.<xref ref-type="bibr" rid="article-19515.r25">[25]</xref><xref ref-type="bibr" rid="article-19515.r26">[26]</xref>&#x000a0;Other cancers, such as breast, liver, and esophageal cancer, are also possible. There is also a&#x000a0;higher incidence of diabetes mellitus. Neurological manifestations occur&#x000a0;later in life with dystonia and choreoathetosis.<xref ref-type="bibr" rid="article-19515.r23">[23]</xref></p>
        <p>
<bold>Bloom Syndrome</bold>
</p>
        <p>Patients with Bloom syndrome can present with a variable combination of symptoms that include disproportionately short stature, microcephaly, immunodeficiency, sinopulmonary infections, decreased intellectual ability, facial anomalies, an erythematous rash associated with sun exposure, caf&#x000e9;-au-lait spot/hypopigmented skin lesions, infertility, a predisposition to hematological malignancies, solid carcinomas and insulin resistance. Short stature is the most striking early symptom that usually drives patients to medical attention.<xref ref-type="bibr" rid="article-19515.r16">[16]</xref><xref ref-type="bibr" rid="article-19515.r19">[19]</xref><xref ref-type="bibr" rid="article-19515.r27">[27]</xref></p>
        <p>
<bold>Fanconi Anemia</bold>
</p>
        <p>Fanconi anemia is an inherited bone marrow failure condition characterized by pancytopenia, cancer predisposition, short stature, microcephaly, developmental delay, and variable anomalies. Anomalies in Fanconi anemia include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Skin hyper- or hypopigmentation</p>
          </list-item>
          <list-item>
            <p>Thumb or other radial ray abnormalities</p>
          </list-item>
          <list-item>
            <p>Hand abnormalities such as clinodactyly</p>
          </list-item>
          <list-item>
            <p>Axial skeletal abnormalities such as short&#x000a0;or webbed neck and vertebral anomalies</p>
          </list-item>
          <list-item>
            <p>Eye malformations</p>
          </list-item>
          <list-item>
            <p>Renal and urinary tract malformations</p>
          </list-item>
          <list-item>
            <p>Gonadal/genital malformations</p>
          </list-item>
          <list-item>
            <p>Ear abnormalities such as middle ear anomalies or atretic ear canal</p>
          </list-item>
          <list-item>
            <p>Congenital heart disease, including patent ductus arteriosus and ventricular septal defect</p>
          </list-item>
          <list-item>
            <p>Gastrointestinal anomalies and central nervous system abnormalities&#x000a0;<xref ref-type="bibr" rid="article-19515.r28">[28]</xref><xref ref-type="bibr" rid="article-19515.r29">[29]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Nijmegen Breakage Syndrome&#x000a0;</bold>
</p>
        <p>Nijmegen breakage syndrome shows progressive symptoms that include microcephaly, facial deformities with "bird-like" faces, intrauterine growth retardation, intellectual&#x000a0;disability, immunodeficiency with recurrent sinopulmonary infections, a predisposition to lymphoid malignancies, primary ovarian insufficiency, and radiosensitivity.<xref ref-type="bibr" rid="article-19515.r30">[30]</xref></p>
      </sec>
      <sec id="article-19515.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Ataxia-Telangiectasia</bold>
</p>
        <p>Diagnostic evaluation for&#x000a0;ataxia-telangiectasia includes a combination of ataxia with&#x000a0;1 or more of the following: telangiectasia, sinopulmonary disease, or imaging studies (especially with brain magnetic resonance imaging) showing diffuse cerebellar atrophy. Investigations for ataxia-telangiectasia should include&#x000a0;a complete blood count (CBC) with lymphopenia; serological testing shows increased alpha-fetoprotein&#x000a0;(the most consistent test in ataxia-telangiectasia)<xref ref-type="bibr" rid="article-19515.r31">[31]</xref>&#x000a0;and decreased immunoglobulin (Ig)A, IgG, and IgE. The most specific test is for the genetic mutation in the <italic toggle="yes">ATM</italic> gene or lack of ATM protein kinase. Of note is that antenatal diagnosis is possible by identifying <italic toggle="yes">ATM</italic> gene mutations.<xref ref-type="bibr" rid="article-19515.r23">[23]</xref></p>
        <p>
<bold>Bloom Syndrome</bold>
</p>
        <p>The investigation for Bloom syndrome focuses on assessing immunodeficiency. Tests include serology and CBC, where CBC shows lymphopenia. Serological testing shows decreased immunoglobulin levels (IgA, IgG, and IgE).</p>
        <p>
<bold>Fanconi&#x000a0;Anemia</bold>
</p>
        <p>Investigation for Fanconi anemia includes chromosomal stress testing and next-generation sequencing panels. Chromosomal stress testing involves the assessment of chromosomal breakage in T-lymphocytes from peripheral blood upon exposure of cells to diepoxybutane or mitomycin C. The test is sensitive but not specific because other rare genetic diseases can also show breakage. Flow cytometry, which assesses cell cycle analysis upon exposure to DNA cross-linking agents, is another helpful test in evaluating this condition. In Franconi anemia, cells cannot repair DNA damage and undergo cell cycle arrest in G2, leading to a higher percentage of cells in G2. Gene sequencing for this condition is generally used as a confirmatory tool for patients with positive breakage studies.<xref ref-type="bibr" rid="article-19515.r32">[32]</xref></p>
        <p>
<bold>Nijmegen Breakage Syndrome</bold>
</p>
        <p>Investigation for Nijmegen breakage syndrome focuses on the assessment of immunodeficiency. Tests include assessment of immunoglobulin levels, cluster of differentiation (CD) 4, CD8, CD19, CD57, and class switching of memory B cells. Karyotyping sometimes shows structural chromosomal aberrations in T= lymphocytes at chromosomes 7 and 14. There is also sensitivity to ionizing radiation. There are also mutations in the <italic toggle="yes">NBN</italic> gene and the absence of fibrin protein.<xref ref-type="bibr" rid="article-19515.r30">[30]</xref></p>
      </sec>
      <sec id="article-19515.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Ataxia-Telangiectasia</bold>
</p>
        <p>Treatment of&#x000a0;ataxia-telangiectasia is symptomatic and supportive and includes physical rehabilitation to cope with the ataxia, prompt treatment of infections, and management of diabetes mellitus.</p>
        <p>
<bold>Bloom Syndrome</bold>
</p>
        <p>Treatment of Bloom syndrome is symptomatic and includes immediate treatment of infections and periodic surveillance for cancer; patients should avoid sun and radiation exposure.</p>
        <p>
<bold>Fanconi Anemia</bold>
</p>
        <p>Management of Fanconi anemia focuses on managing&#x000a0;bone marrow&#x000a0;failure, cancer surveillance, and control of organ dysfunction. The only curative option for this condition is allogeneic hematopoietic cell transplantation. Supportive therapeutic options include androgen therapy to increase blood cell count, the use of granulocyte colony-stimulating factor, and blood product transfusions.<xref ref-type="bibr" rid="article-19515.r33">[33]</xref></p>
        <p>
<bold>Nijmegen Breakage Syndrome</bold>
</p>
        <p>Management of Nijmegen breakage syndrome focuses on symptomatic treatment. Prompt management of immunodeficiency as appropriate with antibiotics and intravenous immunoglobulins&#x000a0;to reduce morbidity and mortality in Nijmegen breakage syndrome patients.<xref ref-type="bibr" rid="article-19515.r34">[34]</xref></p>
      </sec>
      <sec id="article-19515.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>
<bold>Ataxia-Telangiectasia</bold>
</p>
        <p>The differential diagnoses of ataxia-telangiectasia include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cerebral palsy</p>
          </list-item>
          <list-item>
            <p>Friedreich ataxia</p>
          </list-item>
          <list-item>
            <p>Gaucher disease</p>
          </list-item>
          <list-item>
            <p>Niemann-Pick disease</p>
          </list-item>
        </list>
        <p>
<bold>Bloom Syndrome</bold>
</p>
        <p>The differential diagnoses of Bloom syndrome include other disorders that present with short stature, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Skeletal dysplasia</p>
          </list-item>
          <list-item>
            <p>Growth hormone deficiency</p>
          </list-item>
          <list-item>
            <p>Constitutional delay</p>
          </list-item>
        </list>
        <p>
<bold>Fanconi Anemia</bold>
</p>
        <p>The&#x000a0;differential diagnoses of Fanconi anemia include other diseases presenting with bone marrow failure, such as:</p>
        <list list-type="bullet">
          <list-item>
            <p>Acquired aplastic anemia</p>
          </list-item>
          <list-item>
            <p>Paroxysmal nocturnal hemoglobinuria</p>
          </list-item>
          <list-item>
            <p>Other inherited bone marrow failure syndromes</p>
          </list-item>
          <list-item>
            <p>Drug-induced or infection-associated pancytopenia</p>
          </list-item>
          <list-item>
            <p>Nijmegen breakage syndrome</p>
          </list-item>
          <list-item>
            <p>Bloom syndrome</p>
          </list-item>
          <list-item>
            <p>Ataxia-telangiectasia</p>
          </list-item>
          <list-item>
            <p>DNA ligase IV syndrome&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Non-homologous end-joining factor 1&#x000a0;deficiency&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Seckel syndrome (ATR)</p>
          </list-item>
          <list-item>
            <p>Roberts syndrome (ESCO2)</p>
          </list-item>
          <list-item>
            <p>Warsaw breakage syndrome (DDX11)</p>
          </list-item>
          <list-item>
            <p>De novo myelodysplastic syndrome&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Nijmegen breakage syndrome</bold>
</p>
        <p>The differential diagnoses of Nijmegen breakage syndrome include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ataxia-telangiectasia</p>
          </list-item>
          <list-item>
            <p>Ataxia-telangiectasia&#x02013;like disease</p>
          </list-item>
          <list-item>
            <p>Fanconi anemia</p>
          </list-item>
          <list-item>
            <p>Bloom syndrome</p>
          </list-item>
          <list-item>
            <p>RAD50 deficiency</p>
          </list-item>
          <list-item>
            <p>Seckel syndrome&#x000a0;<xref ref-type="bibr" rid="article-19515.r35">[35]</xref><xref ref-type="bibr" rid="article-19515.r36">[36]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Cancers in Chromosomal Instability Disorders&#x000a0;</bold>
</p>
        <p>Differentials for cancers in chromosomal instability disorders include cancer syndromes secondary to oncogene and tumor suppressor gene mutations.<xref ref-type="bibr" rid="article-19515.r37">[37]</xref><xref ref-type="bibr" rid="article-19515.r38">[38]</xref></p>
      </sec>
      <sec id="article-19515.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognoses for these chromosomal instability syndromes are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Ataxia-Telangiectasia: </bold>This condition has a variable rate of progression; with the classic form, most patients have a poor quality of life and high mortality by early adulthood.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Bloom Syndrome:&#x000a0;</bold>Most patients with Bloom syndrome survive to adulthood; cancer surveillance has&#x000a0;demonstrated an association with improved outcomes.</p>
          </list-item>
          <list-item>
            <p><bold>Fanconi anemia:</bold>&#x000a0;This condition is stratified and managed based on the severity of bone marrow failure.</p>
          </list-item>
          <list-item>
            <p><bold>Nijmegen breakage syndrome: </bold>This condition depends on the severity of the patient's symptoms and infection management strategies.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19515.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of chromosomal instability include an increased predisposition to cancer, infections, and organ dysfunction.</p>
      </sec>
      <sec id="article-19515.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Many chromosomal instability syndromes run in families; early management can be the key to a better prognosis&#x000a0;for these patients.</p>
      </sec>
      <sec id="article-19515.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Chromosomal instability syndromes are rare disease entities that need interprofessional team management, including genetic counseling, infectious disease consultation, and tailored cancer surveillance programs.</p>
      </sec>
      <sec id="article-19515.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19515&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19515">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/chromosome-instability-syndromes/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=19515">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19515/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19515">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-19515.s15">
        <title>References</title>
        <ref id="article-19515.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taylor</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Chromosome instability syndromes.</article-title>
            <source>Best Pract Res Clin Haematol</source>
            <year>2001</year>
            <month>Sep</month>
            <volume>14</volume>
            <issue>3</issue>
            <fpage>631</fpage>
            <page-range>631-44</page-range>
            <pub-id pub-id-type="pmid">11640873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taylor</surname>
                <given-names>AMR</given-names>
              </name>
              <name>
                <surname>Rothblum-Oviatt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Hickson</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Crawford</surname>
                <given-names>TO</given-names>
              </name>
              <name>
                <surname>Smogorzewska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pietrucha</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Weemaes</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>GS</given-names>
              </name>
            </person-group>
            <article-title>Chromosome instability syndromes.</article-title>
            <source>Nat Rev Dis Primers</source>
            <year>2019</year>
            <month>Sep</month>
            <day>19</day>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>64</fpage>
            <pub-id pub-id-type="pmid">31537806</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perlman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Becker-Catania</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gatti</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Ataxia-telangiectasia: diagnosis and treatment.</article-title>
            <source>Semin Pediatr Neurol</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>173</fpage>
            <page-range>173-82</page-range>
            <pub-id pub-id-type="pmid">14653405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amor-Gu&#x000e9;ret</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Bloom syndrome, genomic instability and cancer: the SOS-like hypothesis.</article-title>
            <source>Cancer Lett</source>
            <year>2006</year>
            <month>May</month>
            <day>08</day>
            <volume>236</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-12</page-range>
            <pub-id pub-id-type="pmid">15950375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>ZH</given-names>
              </name>
            </person-group>
            <article-title>The concept and practice of Fanconi Anemia: from the clinical bedside to the laboratory bench.</article-title>
            <source>Transl Pediatr</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>112</fpage>
            <page-range>112-9</page-range>
            <pub-id pub-id-type="pmid">26835301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weemaes</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Hustinx</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Scheres</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>van Munster</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Bakkeren</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Taalman</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>A new chromosomal instability disorder: the Nijmegen breakage syndrome.</article-title>
            <source>Acta Paediatr Scand</source>
            <year>1981</year>
            <month>Jul</month>
            <volume>70</volume>
            <issue>4</issue>
            <fpage>557</fpage>
            <page-range>557-64</page-range>
            <pub-id pub-id-type="pmid">7315300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stewart</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Maser</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Stankovic</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bressan</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Jaspers</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Raams</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Byrd</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Petrini</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder.</article-title>
            <source>Cell</source>
            <year>1999</year>
            <month>Dec</month>
            <day>10</day>
            <volume>99</volume>
            <issue>6</issue>
            <fpage>577</fpage>
            <page-range>577-87</page-range>
            <pub-id pub-id-type="pmid">10612394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weemaes</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>van Tol</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>van Ostaijen-ten Dam</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>van Eggermond</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Thijssen</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Aytekin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brunetti-Pierri</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>van der Burg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Graham Davies</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ferster</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Furthner</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gimelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gennery</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kloeckener-Gruissem</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Meyn</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Reisli</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Schuetz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schulz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shugar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van den Elsen</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>van der Maarel</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects.</article-title>
            <source>Eur J Hum Genet</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>21</volume>
            <issue>11</issue>
            <fpage>1219</fpage>
            <page-range>1219-25</page-range>
            <pub-id pub-id-type="pmid">23486536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karikkineth</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Scheibye-Knudsen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fivenson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Croteau</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Bohr</surname>
                <given-names>VA</given-names>
              </name>
            </person-group>
            <article-title>Cockayne syndrome: Clinical features, model systems and pathways.</article-title>
            <source>Ageing Res Rev</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>33</volume>
            <fpage>3</fpage>
            <page-range>3-17</page-range>
            <pub-id pub-id-type="pmid">27507608</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kraemer</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Patronas</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Schiffmann</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Brooks</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Tamura</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>DiGiovanna</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship.</article-title>
            <source>Neuroscience</source>
            <year>2007</year>
            <month>Apr</month>
            <day>14</day>
            <volume>145</volume>
            <issue>4</issue>
            <fpage>1388</fpage>
            <page-range>1388-96</page-range>
            <pub-id pub-id-type="pmid">17276014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soza</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Leva</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Vago</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mazzini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Biamonti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Montecucco</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>DNA ligase I deficiency leads to replication-dependent DNA damage and impacts cell morphology without blocking cell cycle progression.</article-title>
            <source>Mol Cell Biol</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>29</volume>
            <issue>8</issue>
            <fpage>2032</fpage>
            <page-range>2032-41</page-range>
            <pub-id pub-id-type="pmid">19223467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wimmer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kratz</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Constitutional mismatch repair-deficiency syndrome.</article-title>
            <source>Haematologica</source>
            <year>2010</year>
            <month>May</month>
            <volume>95</volume>
            <issue>5</issue>
            <fpage>699</fpage>
            <page-range>699-701</page-range>
            <pub-id pub-id-type="pmid">20442441</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsai</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Cernunnos/XLF promotes the ligation of mismatched and noncohesive DNA ends.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>2007</year>
            <month>May</month>
            <day>08</day>
            <volume>104</volume>
            <issue>19</issue>
            <fpage>7851</fpage>
            <page-range>7851-6</page-range>
            <pub-id pub-id-type="pmid">17470781</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rothblum-Oviatt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lefton-Greif</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>McGrath-Morrow</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Crawford</surname>
                <given-names>TO</given-names>
              </name>
              <name>
                <surname>Lederman</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Ataxia telangiectasia: a review.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2016</year>
            <month>Nov</month>
            <day>25</day>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>159</fpage>
            <pub-id pub-id-type="pmid">27884168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shahrabani-Gargir</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shomrat</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yaron</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Orr-Urtreger</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Groden</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Legum</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin.</article-title>
            <source>Genet Test</source>
            <year>1998</year>
            <volume>2</volume>
            <issue>4</issue>
            <fpage>293</fpage>
            <page-range>293-6</page-range>
            <pub-id pub-id-type="pmid">10464606</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cunniff</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bassetti</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Bloom's Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition.</article-title>
            <source>Mol Syndromol</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>4</fpage>
            <page-range>4-23</page-range>
            <pub-id pub-id-type="pmid">28232778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Winter</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Joenje</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>The genetic and molecular basis of Fanconi anemia.</article-title>
            <source>Mutat Res</source>
            <year>2009</year>
            <month>Jul</month>
            <day>31</day>
            <volume>668</volume>
            <issue>1-2</issue>
            <fpage>11</fpage>
            <page-range>11-9</page-range>
            <pub-id pub-id-type="pmid">19061902</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Varon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Seemanova</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chrzanowska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hnateyko</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Piekutowska-Abramczuk</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Krajewska-Walasek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sykut-Cegielska</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sperling</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Reis</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Clinical ascertainment of Nijmegen breakage syndrome (NBS) and prevalence of the major mutation, 657del5, in three Slav populations.</article-title>
            <source>Eur J Hum Genet</source>
            <year>2000</year>
            <month>Nov</month>
            <volume>8</volume>
            <issue>11</issue>
            <fpage>900</fpage>
            <page-range>900-2</page-range>
            <pub-id pub-id-type="pmid">11093281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>German</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sanz</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Ciocci</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ye</surname>
                <given-names>TZ</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Syndrome-causing mutations of the BLM gene in persons in the Bloom's Syndrome Registry.</article-title>
            <source>Hum Mutat</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>28</volume>
            <issue>8</issue>
            <fpage>743</fpage>
            <page-range>743-53</page-range>
            <pub-id pub-id-type="pmid">17407155</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naim</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Rosselli</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities.</article-title>
            <source>Nat Cell Biol</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>761</fpage>
            <page-range>761-8</page-range>
            <pub-id pub-id-type="pmid">19465921</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sagan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kr&#x000f6;ger</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hematulin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>M&#x000f6;rtl</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Eckardt-Schupp</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>The DNA repair protein NBS1 influences the base excision repair pathway.</article-title>
            <source>Carcinogenesis</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>408</fpage>
            <page-range>408-15</page-range>
            <pub-id pub-id-type="pmid">19126654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Digweed</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sperling</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks.</article-title>
            <source>DNA Repair (Amst)</source>
            <year>2004</year>
            <season>Aug-Sep</season>
            <volume>3</volume>
            <issue>8-9</issue>
            <fpage>1207</fpage>
            <page-range>1207-17</page-range>
            <pub-id pub-id-type="pmid">15279809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Verhagen</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Abdo</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Willemsen</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Hogervorst</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Smeets</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Hiel</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Brunt</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>van Rijn</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Majoor Krakauer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Oldenburg</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Broeks</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Last</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>van't Veer</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Tijssen</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Dubois</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Kremer</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Weemaes</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>van Deuren</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Clinical spectrum of ataxia-telangiectasia in adulthood.</article-title>
            <source>Neurology</source>
            <year>2009</year>
            <month>Aug</month>
            <day>11</day>
            <volume>73</volume>
            <issue>6</issue>
            <fpage>430</fpage>
            <page-range>430-7</page-range>
            <pub-id pub-id-type="pmid">19535770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Staples</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>McDermott</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Reiman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Byrd</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Ritchie</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>EG</given-names>
              </name>
            </person-group>
            <article-title>Immunodeficiency in ataxia telangiectasia is correlated strongly with the presence of two null mutations in the ataxia telangiectasia mutated gene.</article-title>
            <source>Clin Exp Immunol</source>
            <year>2008</year>
            <month>Aug</month>
            <volume>153</volume>
            <issue>2</issue>
            <fpage>214</fpage>
            <page-range>214-20</page-range>
            <pub-id pub-id-type="pmid">18505428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boultwood</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Ataxia telangiectasia gene mutations in leukaemia and lymphoma.</article-title>
            <source>J Clin Pathol</source>
            <year>2001</year>
            <month>Jul</month>
            <volume>54</volume>
            <issue>7</issue>
            <fpage>512</fpage>
            <page-range>512-6</page-range>
            <pub-id pub-id-type="pmid">11429421</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taylor</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Metcalfe</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Thick</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mak</surname>
                <given-names>YF</given-names>
              </name>
            </person-group>
            <article-title>Leukemia and lymphoma in ataxia telangiectasia.</article-title>
            <source>Blood</source>
            <year>1996</year>
            <month>Jan</month>
            <day>15</day>
            <volume>87</volume>
            <issue>2</issue>
            <fpage>423</fpage>
            <page-range>423-38</page-range>
            <pub-id pub-id-type="pmid">8555463</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Kerckhove</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Ceuppens</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Vanderschueren-Lodeweyckx</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eggermont</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vertessen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Bloom's syndrome. Clinical features and immunologic abnormalities of four patients.</article-title>
            <source>Am J Dis Child</source>
            <year>1988</year>
            <month>Oct</month>
            <volume>142</volume>
            <issue>10</issue>
            <fpage>1089</fpage>
            <page-range>1089-93</page-range>
            <pub-id pub-id-type="pmid">3263039</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soulier</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Fanconi anemia.</article-title>
            <source>Hematology Am Soc Hematol Educ Program</source>
            <year>2011</year>
            <volume>2011</volume>
            <fpage>492</fpage>
            <page-range>492-7</page-range>
            <pub-id pub-id-type="pmid">22160080</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garaycoechea</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Why does the bone marrow fail in Fanconi anemia?</article-title>
            <source>Blood</source>
            <year>2014</year>
            <month>Jan</month>
            <day>02</day>
            <volume>123</volume>
            <issue>1</issue>
            <fpage>26</fpage>
            <page-range>26-34</page-range>
            <pub-id pub-id-type="pmid">24200684</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chrzanowska</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Gregorek</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dembowska-Bagi&#x00144;ska</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kalina</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Digweed</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Nijmegen breakage syndrome (NBS).</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2012</year>
            <month>Feb</month>
            <day>28</day>
            <volume>7</volume>
            <fpage>13</fpage>
            <pub-id pub-id-type="pmid">22373003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stray-Pedersen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Borresen-Dale</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Paus</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lindman</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Burgers</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Abrahamsen</surname>
                <given-names>TG</given-names>
              </name>
            </person-group>
            <article-title>Alpha fetoprotein is increasing with age in ataxia-telangiectasia.</article-title>
            <source>Eur J Paediatr Neurol</source>
            <year>2007</year>
            <month>Nov</month>
            <volume>11</volume>
            <issue>6</issue>
            <fpage>375</fpage>
            <page-range>375-80</page-range>
            <pub-id pub-id-type="pmid">17540590</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oostra</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Nieuwint</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Joenje</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>de Winter</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of fanconi anemia: chromosomal breakage analysis.</article-title>
            <source>Anemia</source>
            <year>2012</year>
            <volume>2012</volume>
            <fpage>238731</fpage>
            <pub-id pub-id-type="pmid">22693659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MacMillan</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Haematopoeitic cell transplantation for Fanconi anaemia - when and how?</article-title>
            <source>Br J Haematol</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>149</volume>
            <issue>1</issue>
            <fpage>14</fpage>
            <page-range>14-21</page-range>
            <pub-id pub-id-type="pmid">20136826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r34">
          <label>34</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Arumugham</surname>
                <given-names>VB</given-names>
              </name>
              <name>
                <surname>Rayi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Intravenous Immunoglobulin (IVIG)</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>3</day>
            <pub-id pub-id-type="pmid">32119333</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Waltes</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kalb</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gatei</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kijas</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Stumm</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sobeck</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wieland</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Varon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lerenthal</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lavin</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Schindler</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>D&#x000f6;rk</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder.</article-title>
            <source>Am J Hum Genet</source>
            <year>2009</year>
            <month>May</month>
            <volume>84</volume>
            <issue>5</issue>
            <fpage>605</fpage>
            <page-range>605-16</page-range>
            <pub-id pub-id-type="pmid">19409520</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Griffith</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Vagnarelli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Stiff</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vernay</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Al Sanna</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Saggar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hamel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Earnshaw</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Jeggo</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Jackson</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>O'Driscoll</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling.</article-title>
            <source>Nat Genet</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>232</fpage>
            <page-range>232-6</page-range>
            <pub-id pub-id-type="pmid">18157127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r37">
          <label>37</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Joyce</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rayi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kasi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Tumor-Suppressor Genes</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>28</day>
            <pub-id pub-id-type="pmid">30335276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19515.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Larsson</surname>
                <given-names>LG</given-names>
              </name>
            </person-group>
            <article-title>Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence.</article-title>
            <source>Semin Cancer Biol</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>367</fpage>
            <page-range>367-76</page-range>
            <pub-id pub-id-type="pmid">22037160</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
